Comparison of Heart-type Fatty Acid Binding Protein (H-FABP), cTnI and CK-MB in Diagnosis of Early AMI
Zhao Shui
Abstract
Zhao Shui
Abstract
Objective To compare the diagnostic efficacy of a newly developed whole blood rapid panel test for heart-type fatty acid binding protein (H-FABP) with that of cardiac troponin I (cTnI) and creatine kinase isoenzyme MB (CK-MB). Methods Eighty-two patients with suspected acute myocardial infarction (AMI) according to certain time frames from onset to presentation. The rapid panel test method was applied to detect the H-FABP and cTnI. The serum CK-MB activity was determined with an immuno-inhibition assay kit. The sensitivity and specificity in diagnosis of early AMI were analyzed between H-FABP and cTnI and CK-MB. Results Final diagnosis was confirmed within 42 patients who were suspected AMI. The overall sensitivities of H-FABP, cTnI and CK-MB were 85.7%, 76.2% and 31.7%, respectively. The relative sensitivities of these 3 markers were 66.7%, 100% and 0% for AMI patients presented within 3h of onset of symptom; 100%, 67% and 67% for those between 3 and 6h. While the relative specificities of these 3 markers were 100%, 50% and 100% within 3h of onset, and 94%, 75% and 100% for those between 3h and 6h. Negative predictive values were 100%, 67% and 84% for patients within 6h of onset. Conclusions H-FABP is more sensitive and specific in diagnosis of early AMI, which may has great potential as an excellent biochemical cardiac marker for diagnosis of AMI in the early phase.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To compare the diagnostic efficacy of a newly developed whole blood rapid panel test for heart-type fatty acid binding protein (H-FABP) with that of cardiac troponin I (cTnI) and creatine kinase isoenzyme MB (CK-MB). Methods Eighty-two patients with suspected acute myocardial infarction (AMI) according to certain time frames from onset to presentation. The rapid panel test method was applied to detect the H-FABP and cTnI. The serum CK-MB activity was determined with an immuno-inhibition assay kit. The sensitivity and specificity in diagnosis of early AMI were analyzed between H-FABP and cTnI and CK-MB. Results Final diagnosis was confirmed within 42 patients who were suspected AMI. The overall sensitivities of H-FABP, cTnI and CK-MB were 85.7%, 76.2% and 31.7%, respectively. The relative sensitivities of these 3 markers were 66.7%, 100% and 0% for AMI patients presented within 3h of onset of symptom; 100%, 67% and 67% for those between 3 and 6h. While the relative specificities of these 3 markers were 100%, 50% and 100% within 3h of onset, and 94%, 75% and 100% for those between 3h and 6h. Negative predictive values were 100%, 67% and 84% for patients within 6h of onset. Conclusions H-FABP is more sensitive and specific in diagnosis of early AMI, which may has great potential as an excellent biochemical cardiac marker for diagnosis of AMI in the early phase.
Key concepts: Heart-type fatty acid binding protein, Troponin I, Medicine, Myocardial infarction, Internal medicine, Cardiology, Cardiac marker, Creatine kinase